Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Molecular Biology and Evolution
|
April 2, 2025
Reference-Free Variant Calling with Local Graph Construction with ska lo (SKA)
Romain Derelle, Kieran Madon, Joel Hellewell, et al.
Ebiomedicine
|
March 28, 2026
Elevated body mass index is associated with delayed protective airway mucosal immune responses in mild SARS-CoV-2 infection
Joe Fenn, Rhia Kundu, Janakan Sam Narean, et al.
Ebiomedicine
|
June 5, 2025
Early de novo T cell expansion following SARS-CoV-2 infection predicts favourable clinical and virological outcomes
Joe Fenn, Aleksandra Koycheva, Rhia Kundu, et al.
Ebiomedicine
|
December 12, 2024
An ultra-early, transient interferon-associated innate immune response associates with protection from SARS-CoV-2 infection despite exposure
Joe Fenn, Kieran Madon, Emily Conibear, et al.
Mucosal Immunology
|
November 23, 2023
A pro-inflammatory gut mucosal cytokine response is associated with mild COVID-19 disease and superior induction of serum antibodies
Dana Costigan, Joe Fenn, Sandi Yen, et al.
The European Respiratory Journal
|
November 26, 2021
Broadening symptom criteria improves early case identification in SARS-CoV-2 contacts
Hamish Houston, Seran Hakki, Timesh D Pillay, et al.
Nature Communications
|
November 30, 2024
SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infections
Joshua Rosenheim, Rishi K Gupta, Clare Thakker, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Molecular Biology and Evolution
|
April 2, 2025
Reference-Free Variant Calling with Local Graph Construction with ska lo (SKA)
Romain Derelle, Kieran Madon, Joel Hellewell, et al.
Ebiomedicine
|
March 28, 2026
Elevated body mass index is associated with delayed protective airway mucosal immune responses in mild SARS-CoV-2 infection
Joe Fenn, Rhia Kundu, Janakan Sam Narean, et al.
Ebiomedicine
|
June 5, 2025
Early de novo T cell expansion following SARS-CoV-2 infection predicts favourable clinical and virological outcomes
Joe Fenn, Aleksandra Koycheva, Rhia Kundu, et al.
Ebiomedicine
|
December 12, 2024
An ultra-early, transient interferon-associated innate immune response associates with protection from SARS-CoV-2 infection despite exposure
Joe Fenn, Kieran Madon, Emily Conibear, et al.
Mucosal Immunology
|
November 23, 2023
A pro-inflammatory gut mucosal cytokine response is associated with mild COVID-19 disease and superior induction of serum antibodies
Dana Costigan, Joe Fenn, Sandi Yen, et al.
The European Respiratory Journal
|
November 26, 2021
Broadening symptom criteria improves early case identification in SARS-CoV-2 contacts
Hamish Houston, Seran Hakki, Timesh D Pillay, et al.
Nature Communications
|
November 30, 2024
SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infections
Joshua Rosenheim, Rishi K Gupta, Clare Thakker, et al.
Page
of 1